Arcadia Biosciences, Inc.
For the period ended Dec 31, 2025. Filed Mar 26, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 26, 2026
RKDA$0.17-0.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
Consolidated Statem ents of Cash Flows
(In thousands)
| Year Ended December 31, | ||
|---|---|---|
| 2025 | 2024 | |
| CASH FLOWS FROM OPERATING ACTIVITIES: | ||
| Net loss | $(2,339) | $(7,038) |
| Adjustments to reconcile net loss to cash used in operating activities: | ||
| Change in fair value of common stock warrant and option liabilities | (2,384) | 1,474 |
| Change in fair value of contingent consideration | (2,000) | |
| Depreciation | 32 | 113 |
| Lease amortization | 122 | 652 |
| Amortization of note receivable discount | (69) | (157) |
| Gain on disposal of property and equipment | — | (65) |
| Gain on sale of intangible assets | (750) | (4,000) |
| Gain on receipt of Above Food Ingredients, Inc. common stock | (1,067) | — |
| Unrealized gain subsequent to receipt of Above Food Ingredients, Inc. common stock | (1,237) | — |
| Stock-based compensation | 234 | 512 |
| Credit loss | 4,745 | — |
| Write-down of inventories | — | 154 |
| Impairment of property and equipment | — | 36 |
| Write-down of non-controlling interest | — | 138 |
| Changes in operating assets and liabilities: | ||
| Accounts receivable and other receivables | 165 | (762) |
| Inventories | (308) | 550 |
| Prepaid expenses and other current assets | 775 | (124) |
| Other noncurrent assets | (50) | 72 |
| Accounts payable and accrued expenses | (399) | (303) |
| Amounts due to related parties | (30) | (29) |
| Other current liabilities | (57) | — |
| Operating lease payments | (122) | (850) |
| Net cash used in operating activities | (4,739) | (9,627) |
| CASH FLOWS FROM INVESTING ACTIVITIES: | ||
| Proceeds from sale of property and equipment | — | 334 |
| Proceeds from sale of investments | — | 5,024 |
| Proceeds from sale of intangible assets | 750 | 4,000 |
| Cash paid related to sale of GoodWheat | — | (2,000) |
| Purchases of property and equipment | — | (16) |
| Net cash provided by investing activities | 750 | 7,342 |
| CASH FLOWS FROM FINANCING ACTIVITIES: | ||
| Proceeds from ESPP purchases | 6 | 9 |
| Net cash provided by financing activities | 6 | 9 |
| Net decrease in cash and cash equivalents | (3,983) | (2,276) |
| Cash and cash equivalents — beginning of period | 4,242 | 6,518 |
| Cash and cash equivalents — end of period | $259 | $4,242 |
| SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION: | ||
| NONCASH TRANSACTIONS: | ||
| Right of use assets obtained in exchange for new operating lease liabilities | $— | $86 |
| Note receivable recognized from sale of GoodWheat | $— | $5,705 |
| Fair value of Above Food Ingredients, Inc. common stock received | $3,067 | $— |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.